Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
makeover games
Popular Articles

Patients Have 'Mixed Views' On Electronic Health Records
Two-thirds of patients are happy for their medical records to be stored electronically, according to a snapshot survey carried out in a community mental health setting. But many patients still have concerns about security and confidentiality.

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published In SCIENCE
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced that scientists reporting in the July 31 issue of SCIENCE have discovered a key disease-related biologic pathway using an integrated and innovative array of in vitro readouts and advanced in vivo imaging technologies. The newly reported biologic pathway relates to monocyte deployment from the spleen to inflammatory sites, including myocardial infarction. The findings are expected to open up new areas of research and potentially advance therapeutic approaches to key disease areas including inflammation and myocardial injury.
News of the day
NACDS To Honor Len DeMino At NACDS Pharmacy & Technology Conference As Industry Icon Announces Retirement As Consultant To The Association
The National Association of Chain Drug Stores (NACDS) today announced that the 2009 NACDS Pharmacy & Technology Conference will provide a forum at which to provide further recognition to Leonard J. DeMino, RPh., a chain pharmacy icon whose resume already includes some of the industry"s highest honors and achievements. This news comes as DeMino announces his retirement as senior pharmacy consultant to NACDS, effective in June 2009.
Sexual Health

Upcoming BioAlliance Pharma's Presentations At International Conferences On Infectious Diseases And Oncology

BioAlliance Pharma SA (Paris:BIO), a company dedicated to therapies and supportive care for cancer and AIDS patients, announced its scientific communications at upcoming international conferences on infectious diseases and oncology: Loramyc®, indicated for fungal infections in immune-compromised patients with HIV or cancer The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 to June 2, 2009 - Orlando, Florida, USA. Abstract: "Prevalence and management of oropharyngeal candidiasis (OPC) by medical and radiation oncologists in cancer patients". At the American Conference for the Treatment of HIV (ACTHIV) that took place on May 15-17, 2009 in Denver, Colorado, USA, BioAlliance Pharma presented the poster: "Once-Daily Miconazole Mucoadhesive Buccal Tablet is an Effective and Safe Treatment for Oropharyngeal Candidiasis". Amep™, a biotherapy for Metastatic Melanoma treatment American Society of Gene Therapy (ASGT) 12th Annual Meeting May 27-30, 2009 - San Diego, California, USA Poster: "Complete Melanoma Regressions after Electrotransfer of the p-AMEP™ Plasmid Coding for an Anti-Angiogenic and Anti-Metastatic Peptide", May 28. Anti-integrases: new antiretroviral drugs for the treatment of resistant HIV-1 XVIII International HIV Drug Resistance Workshop June 9-13, 2009 - Fort Myers, Florida, USA Oral communication and poster: "New integrase binding inhibitors acting in synergy with Raltegravir", June 12. Irinotecan SRN oral formulation for the treatment of advanced colorectal cancer 2nd Pharmaceutical Sciences Fair and Exhibition (PharmSciFair) June 8-12, 2009, Nice, France Oral communication: "Sustained Release Nanoparticles (SRN) for oral administration of Irinotecan", June 10. BioAlliance Pharma


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009